Sana Biotechnology, Inc.

The momentum for this stock is not very good. Sana Biotechnology, Inc. has good growth characteristics. Sana Biotechnology, Inc. is a mediocre stock to choose.

News

Sana Biotechnology CFO Nathan Hardy resigns, effective October 4

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Sana Biotechnology (NASDAQ:SANA) Trading Down 4.8%

Ticker Report Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) dropped 4.8% during trading on Friday . The company traded as low as $5.13 and last traded at $5.15. Approximately 135,053 shares changed...\n more…

Sana Biotechnology Insider Lowered Holding By 14% During Last Year

Simply Wall St From what we can see, insiders were net sellers in Sana Biotechnology, Inc.'s ( NASDAQ:SANA ) during the past 12...\n more…

Sana Biotechnology to Present at September 2024 Investor Conferences

Globe Newswire SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will...\n more…

Sana Biotechnology names its first chief scientific officer

BizJournals.com - Nat'l Business News The hire comes after Sana opened its new manufacturing facility in Bothell earlier this month.\n more…

Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer

Globe Newswire SEATTLE, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment...\n more…